Virpax Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$253K

54 transactions

Summary

Virpax Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $253KSales: —16 insiders

Date	Insider	Type	Value
2024-07-05	Dhaliwal Jatinder	A	$0
2024-07-05	Herman Gary L	A	$0
2024-07-05	Field Katharyn	A	$0
2024-01-29	Ruskin Barbara	A	$0
2024-01-29	Floyd Eric	A	$0
2024-01-29	Bruce Gerald W(Chief Executive Officer)	A	$0
2024-01-29	Sendrow Jerrold	A	$0
2024-01-29	Dubin Michael F	A	$0
2024-01-29	Mathias Sheila(Chief Scientific Officer)	A	$0
2024-01-29	Jambulingam Thani	A	$0
2024-01-29	Shah Vinay(Chief Financial Officer)	A	$0
2024-01-29	Singh Vanila	A	$0
2023-06-20	Shah Vinay(Chief Financial Officer)	A	$0
2023-06-20	Shah Vinay(Chief Financial Officer)	A	$0
2023-04-24	Bruce Gerald W	A	$0
2023-03-24	Ruskin Barbara	A	$0
2023-01-25	Chipman Christopher Michael(Chief Financial Officer)	A	$0
2023-01-25	Mack Anthony P.(Chief Executive Officer)	A	$0
2023-01-25	Gudin Jeffrey(Chief Medical Officer)	A	$0
2023-01-25	Mack Anthony P.(Chief Executive Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Virpax Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope